Plasma visfatin levels in severe obstructive sleep apnea—hypopnea syndrome
Background Obstructive sleep apnea syndrome (OSAS) is associated with obesity and insulin resistance. Visfatin is an insulin-mimicking adipokine, which is considered a link between obesity and insulin resistance. Aim of this study was to evaluate levels of plasma visfatin in patients with severe OSA...
Gespeichert in:
Veröffentlicht in: | Sleep & breathing 2009-11, Vol.13 (4), p.349-355 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Obstructive sleep apnea syndrome (OSAS) is associated with obesity and insulin resistance. Visfatin is an insulin-mimicking adipokine, which is considered a link between obesity and insulin resistance. Aim of this study was to evaluate levels of plasma visfatin in patients with severe OSAS and examine their potential correlation with sleep characteristics and several biochemical parameters.
Methods
Nondiabetic patients with severe OSAS (Apnea Hypopnea Index > 30/h,
n
= 32) and healthy controls (Apnea Hypopnea Index |
---|---|
ISSN: | 1520-9512 1522-1709 |
DOI: | 10.1007/s11325-009-0254-6 |